Here are three things to know about Mr. Rose and the announcement:
1. Mr. Rose has held numerous leadership roles with the company over the last decade. He joined RTI in May 2002 as vice president and CFO and was named executive vice president and COO in June 2010. In July 2013, Mr. Rose was named executive vice president of administration.
“Tom has been an integral part of our senior management team for more than 12 years,” said Brian K. Hutchison, RTI’s president and CEO. “He has made a significant impact on our company’s growth and success through his leadership in many different areas of the business. We very much appreciate the experience and dedication Tom has brought to RTI.”
2. During his tenure with the company, RTI has grown from a small tissue processor with one facility in Florida to a multi-location global surgical implant company. RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and distributed in nearly 50 countries.
3. Mr. Rose will continue to serve as corporate secretary for RTI’s board of directors.
More articles on devices:
The future of big orthopedic device companies: Boom or bust?
Stock report: 6 spine, orthopedic device company updates
MiMedx increases 2015 revenue projections by at least 50% — 5 key updates
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
